以触发受体表达于髓细胞-1（TREM-1）和触发受体表达于髓细胞-2（TREM-2）作为治疗靶点：临床挑战与前景

1

Front Immunol. 2024 Dec 16;15:1498993. doi: 10.3389/fimmu.2024.1498993. eCollection 2024.

2

Expert Opin Ther Pat. 2021 Jun;31(6):549-561. doi: 10.1080/13543776.2021.1883587. Epub 2021 Feb 8.

3

J Periodontal Res. 2017 Jun;52(3):512-521. doi: 10.1111/jre.12417. Epub 2016 Sep 14.

4

Front Immunol. 2022 Jun 15;13:907387. doi: 10.3389/fimmu.2022.907387. eCollection 2022.

5

Expert Rev Clin Immunol. 2017 Dec;13(12):1189-1197. doi: 10.1080/1744666X.2017.1392855. Epub 2017 Oct 20.

6

Chest. 2018 Jan;153(1):77-86. doi: 10.1016/j.chest.2017.09.044. Epub 2017 Oct 7.

7

Chin Med J (Engl). 2024 Jul 20;137(14):1663-1673. doi: 10.1097/CM9.0000000000003197. Epub 2024 May 28.

8

Mediators Inflamm. 2020 Jul 1;2020:1798147. doi: 10.1155/2020/1798147. eCollection 2020.

9

Life Sci. 2025 May 15;369:123555. doi: 10.1016/j.lfs.2025.123555. Epub 2025 Mar 9.

10

Mediators Inflamm. 2020 May 14;2020:9501617. doi: 10.1155/2020/9501617. eCollection 2020.

TREM-1 and TREM-2 as therapeutic targets: clinical challenges and perspectives.